跳至主要内容
临床试验/NCT02468401
NCT02468401已完成不适用

The Efficacy of a New Protocol for Preventing Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions

Meir Medical Center1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Changes in glomerular filtration rate following coronary angiography or intervention

研究概览

简要总结

There is a pressing need to find effective strategies for the prevention of contrast induced nephropathy in patients with advanced renal dysfunction. The current study was designed to assess the efficacy of a new protocol for preventing contrast induced nephropathy in patients with advanced renal dysfunction undergoing coronary interventions

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with estimated glomerular filtration rate<45ml/min undergoing coronary angiography due to one of the following indications in accordance with the 2014 guidelines:
  • Elective coronary angiography due to symptoms suggestive for angina with a positive non-invasive ischemia assessment of ≥10% of left ventricle.
  • Non ST-elevation acute coronary syndrome with a GRACE score>110

排除标准

  • Patients on dialysis or those planned for dialysis in the next 3 months.
  • Patients with ST-elevation myocardial infarction
  • No symptoms or signs of heart failure
  • Treatment with IV diuretics during the 48 hours prior to enrolment
  • Patients with acute renal failure (Creatinine raise of at least 0.3mg/dl from )baseline
  • Patients post coronary artery bypass surgery

结局指标

主要结局

Changes in glomerular filtration rate following coronary angiography or intervention

时间窗: 24 and 48 hours post procedure

Significant changes are defined as a reduction ≥25% in glomerular filtration rate

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pereg David

Dr

Meir Medical Center

研究点 (1)

Loading locations...

相似试验